Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
49
GMAB Quote, Financials, Valuation and Earnings
Last price:
$22.03
Seasonality move
:
4.22%
Day range:
$21.41 - $21.89
52-week range:
$17.24 - $28.56
Dividend yield:
0%
P/E ratio:
13.00x
P/S ratio:
4.58x
P/B ratio:
2.54x
Volume:
1M
Avg. volume:
1.4M
1-year change:
-19%
Market cap:
$13.5B
Revenue:
$3B
EPS (TTM):
$1.68
Earnings Data
Next earnings date for GMAB
Aug 07
2025
Most recent earnings per share
$0.31
Beat by $0.08
(May 8/2025)
Consensus Estimate
$0.23
(May 8/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
GMAB Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $958.5M | -- | -- | $0.43 | -- |
| 08/07/2025 | Q2 | $900.9M | -- | -- | $0.34 | -- |
| 05/08/2025 | Q1 | $759.6M | $715M | $0.31 | $0.23 | $0.08 |
| 02/12/2025 | Q4 | $898.3M | $743.8M | $0.77 | $0.28 | $0.49 |
| 11/06/2024 | Q3 | $819.2M | $829.8M | $0.30 | $0.33 | -$0.04 |
| 08/08/2024 | Q2 | $723.6M | $775.5M | $0.31 | $0.32 | -$0.01 |
| 05/02/2024 | Q1 | $572.3M | $603M | $0.29 | $0.14 | $0.15 |
| 02/14/2024 | Q4 | $667.6M | $786.7M | $0.20 | $0.30 | -$0.10 |
| 11/07/2023 | Q3 | $633.2M | $667.4M | $0.45 | $0.31 | $0.14 |
| 08/03/2023 | Q2 | $602.1M | $608.4M | $0.30 | $0.29 | $0.01 |
| 05/10/2023 | Q1 | -- | $414.8M | $0.05 | -- | -- |
| 12/31/2022 | Q4 | -- | $849.5M | $0.20 | -- | -- |
| 11/09/2022 | Q3 | -- | $540.2M | $0.52 | -- | -- |
| 08/10/2022 | Q2 | -- | $443.9M | $0.40 | -- | -- |
| 05/11/2022 | Q1 | -- | $318M | $0.11 | -- | -- |
| 02/16/2022 | Q4 | -- | $366.7M | $0.14 | -- | -- |
| 11/10/2021 | Q3 | -- | $360.4M | $0.21 | -- | -- |
| 08/11/2021 | Q2 | -- | $315.6M | $0.07 | -- | -- |
| 05/05/2021 | Q1 | -- | $249.2M | $0.26 | -- | -- |
| 02/23/2021 | Q4 | -- | $399.2M | $0.19 | -- | -- |
| 11/04/2020 | Q3 | -- | $271.8M | $0.13 | -- | -- |
| 08/12/2020 | Q2 | -- | $822.3M | $0.77 | -- | -- |
| 05/06/2020 | Q1 | -- | $131.7M | $0.06 | -- | -- |
| 02/19/2020 | Q4 | -- | $452.1M | $0.35 | -- | -- |
| 11/06/2019 | Q3 | -- | $152.4M | $0.12 | -- | -- |
| 08/14/2019 | Q2 | -- | $117.9M | $0.02 | -- | -- |
| 03/31/2019 | Q1 | -- | $88.8M | $0.02 | -- | -- |
| 12/31/2018 | Q4 | -- | $185M | $0.20 | -- | -- |
| 09/30/2018 | Q3 | -- | $93.1M | $0.04 | -- | -- |
| 06/30/2018 | Q2 | -- | $79.1M | $0.07 | -- | -- |
| 03/31/2018 | Q1 | -- | $112.6M | $0.05 | -- | -- |
| 12/31/2017 | Q4 | -- | $167.8M | $0.21 | -- | -- |
| 09/30/2017 | Q3 | -- | $51.2M | -$0.00 | -- | -- |
| 06/30/2017 | Q2 | -- | $119M | $0.08 | -- | -- |
| 03/31/2017 | Q1 | -- | $36M | $0.00 | -- | -- |
| 12/31/2016 | Q4 | -- | $123.2M | $0.19 | -- | -- |
| 09/30/2016 | Q3 | -- | $54.9M | $0.05 | -- | -- |
| 06/30/2016 | Q2 | -- | $52.9M | $0.04 | -- | -- |
| 03/31/2016 | Q1 | -- | $25.9M | -$0.00 | -- | -- |
| 12/31/2015 | Q4 | -- | $81.7M | $0.09 | -- | -- |
| 09/30/2015 | Q3 | -- | $41.9M | $0.03 | -- | -- |
Genmab AS Earnings Questions
-
How Much did Genmab AS Generate in Revenue Last Quarter?
Genmab AS reported $715M worth of top line sales in its most recent quarter.
-
Did Genmab AS Beat Earnings Last Quarter?
Genmab AS announced earnings per share of $0.31 which represents a beat of analyst forecast a $0.23 per share.
-
Is Genmab AS Profitable?
Genmab AS reported $673M that represents $1.05 per share over the last quarter.
-
What is the Analyst Consensus for Genmab AS EPS Next Year?
Genmab AS's earnings are forecast to decrease from $1.69 per share to $1.21 per share next year representing a decrease of -20.68%.
-
When is Genmab AS's Earnings Date?
Genmab AS's next earnings date is August 7, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
